LifeVantage CSO Presenting at Biochemical Society Keap1/Nrf2 Pathway in Health and Disease Meeting

Admin   |   13 January, 2015   |   309   |   3980

Shawn M. Talbott, PhD Presenting Regarding Phytonutrient Activation of the Nrf2 Pathway

LifeVantage Corporation (Nasdaq:LFVN), announced that Chief Science Officer Shawn M. Talbott, PhD, is presenting a poster abstract demonstrating a portion of the findings from the research being conducted by LifeVantage in the field of Nrf2, at The Biochemical Society’s Focused Meeting entitled ‘The Keap1/Nrf2 Pathway in Health and Disease’ at Robinson College in Cambridge, UK. Dr. Talbott is presenting about how phytonutrients (plant components such as herbal extracts), found in LifeVantage products, can activate the Nrf2 pathway and improve health and balance metabolism. The Nrf2 pathway is emerging as the body’s central regulator of health and protector from various sources of stress.

The Biochemical Society exists for the advancement of the molecular and cellular biosciences, both as an academic discipline and to promote its impact on areas of science including biotechnology, agriculture, and medicine. Biochemistry helps to play a key role in tackling global issues such as improving lifelong health, treatment of disease, biotechnology and food security.